Snowball logo
logo
TCRX

Tscan Therapeutics Inc

TCRX β€’ NASDAQ
$0.1897-$0.0135Β  (6.64%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
10.1413.5421.052.81610.327.111
COGS
3.3285.13788.154.1079992.866-
Gross Profit
10.1413.5421.052.8167.4596.418
Operating Expenses & Income
Operating Income
(48.64)(66.64)(93.46)(134.8)(135.8)(120.5)
Total Operating Expenses
58.7880.17114.5137.6143.3127
R&D Expenses
44.9559.8288.15107.3114.297.03
Selling General & Admin Expenses
13.8320.3525.4929.5631.9929.79
Earnings from Continuing Operations
Interest Expense
(0.016)(1.176)(3.759)(3.653)(2.769)(2.789)
Interest Income
0.0171.5916.30412.068.8165.619
Income Tax Expense
3.091442(0.415)5.193105---
Net Income
Net Income
(48.63)(66.22)(89.22)(127.5)(129.8)(117.7)
Supplemental
EBIT
(48.63)(65.05)(85.46)(123.8)(127)(114.9)
EBITDA
(45.3)(59.91)(80.1)(119.7)(124.1)(112)
In millions of USD, except % and values per 1 share